INSIGHTS ON PHARMACEUTICAL INSPECTION
-
Why And How To Replace Dye Ingress Test By Deterministic CCIT Methods?
Understand the challenges and limitations of the blue dye test and compare the sensitivity of the blue dye test to other methods based on a comprehensive study.
-
Selecting Container Closure Systems With Confidence: Lyophilization
Experts take you through the entire selection process for primary packaging components for lyophilization and provide aspects to consider for all relevant attributes.
-
Ensuring IV Bag Sterility With Container Closure Integrity Testing Systems
Learn how USP 1207, the reference standard for container closure integrity testing (CCIT), applies to the CCIT inspection method of intravenous (IV) bags.
-
Effects Of X-Ray Inspection On Pharmaceutical Products
Some manufacturers still have reservations about adopting x-ray inspection as a safe method of product inspection. Explore the potential effects of x-ray inspection on pharmaceutical products and more.
-
Replacing Total Moisture Measurements By Water Activity Determination4/19/2022
This short video explains the difference between total moisture content, headspace moisture, and the relation to water activity.
-
Correlating Stopper Height To Container Closure Integrity11/21/2023
Learn how to comply with the new EU Annex 1 Section 8.28. Here, we describe a typical raised-stopper investigation and demonstrate how to generate scientifically robust data using headspace analysis.
-
USP <922> Water Activity Testing For Oral Solid Dose Pharmaceuticals8/26/2022
Gain insight into the technical and regulatory justification for adding water activity measurements into pharmaceutical stability protocols.
-
Container Closure Integrity Of Product Requiring Deep Cold Storage8/26/2022
Gain insight into the risk to container closure integrity (CCI) during deep cold storage and identify appropriate analytical tools, to generate robust data to characterize and mitigate the risk to CCI.
-
Oral Solid Dosage Products: Water Activity And Primary Packaging Selection7/17/2022
Every individual oral solid dosage (OSD) product has different water activity initially and over time. Learn about USP <922> water activity and primary packaging selection of OSD products.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
Our cutting-edge technology and impeccable standards ensure that our customers receive products that meet their exact needs.
-
Optional Data Presence and Readability Inspection for Round and Oriented Products
Product mislabeling is an easily preventable error. When the cost of mislabeled products reaching the marketplace is a product recall, the decision to implement procedures to prevent the error becomes an easy one. This is best accomplished through the use of automated vision inspection to verify product information on the label in production. But limited production space can present a problem when it comes to implementing such a solution. That is where the Product Data Check option for our Product Inspection systems comes in. -
Used Brevetti vial inspection unit, model A1, speeds up to 360 pcs/hour, currently set up for 53.5 mm diameter 100 mL vails, 8mm - 95 mm diameter x up to 240 mm high vial size range, with integrated robotic arm, (4) inspection units, with vial feed infeed and acceptable exit tables, dual reject stations, with HMI panel, serial# BM242, built 2016.
-
The HDI Pinhole Inspector from Nikka Densok offers 100% inspection for BFS vial card production.
-
The physico-chemical properties of the materials have a strong impact on the performance of the entire container system. Container performance analysis embraces a diverse range of investigative fields, such as material, chemical, physical, mechanical engineering. Accurately testing the container performance (product/use-dependent) maximizes drug efficacy as well as device reliability and performance.